Takeda’s Zasocitinib Beats BMS’s Sotyktu In Moderate-To-Severe Plaque Psoriasis Scrip Pharma Intelligence 4d
Roche and Nestlé fear talent crunch as Switzerland puts population cap to the polls Fortune 3d Switzerland Roche Swiss Economy
3 Reasons to buy Eli Lilly stock like there's no tomorrow The Motley Fool 1d Eli Lilly Novo Nordisk Mounjaro
